The presence of anti-LPS antibodies and human serum activity against Proteus mirabilis S/R forms in correlation with TLR4 (Thr399Ile) gene polymorphism in rheumatoid arthritis

Clinical Biochemistry

Volumn 45, Issue 16-17, 2012, Pages 1374-1382

  Arabski, Michal ^a   Fudala, Rafal ^a,b   Koza, Anna ^a   Wasik, Slawomir ^a   Futoma Koloch, Bozena ^c   Bugla Ploskonska, Gabriela ^c   Kaca, Wieslaw ^a  

^a JAN KOCHANOWSKI UNIVERSITY   (Poland)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF WROC AW   (Poland)

Author keywords

Complement; LAL; Laser interferometry; Proteus mirabilis, lipopolysaccharides; Rheumatoid arthritis; TLR4 gene polymorphism

Indexed keywords

ANTIBODY; COMPLEMENT COMPONENT C3D; COMPLEMENT COMPONENT C5B; LIPOPOLYSACCHARIDE ANTIBODY; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN BINDING; ARTICLE; BINDING SITE; BLOOD ANALYSIS; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTERFEROMETRY; LIMULUS LYSATE TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEUS MIRABILIS; RHEUMATOID ARTHRITIS;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM ANALYSIS; ANTIBODIES, BACTERIAL; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; INTERFEROMETRY; LIGHT; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BINDING; PROTEUS MIRABILIS; TOLL-LIKE RECEPTOR 4;

EID: 84868301270     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.06.021     Document Type: Article

References (29)

1. Tobón G.J., Youinou P., Saraux A. The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. J Autoimmun 2010, 35:10-14.
2. Newkirk M.M. Rheumatoid factors: host resistance or autoimmunity?. Clin Immunol 2002, 104:1-13.
3. Rashid T., Ebringer A. Rheumatoid arthritis is linked to Proteus-the evidence. Clin Rheumatol 2007, 26:1036-1043.
4. Senior E.B.W., Anderson G.A., Morley K.D., Kerr M.A. Evidence that patients with rheumatoid arthritis have asymptomatic 'non-significant' Proteus mirabilis bacteriuria more frequently than healthy controls. J Infect 1999, 38:99-106.
5. Tiwana H., Wilson C., Pirt J., Cartmell W., Ebringer A. Autoantibodies to brain components and antibodies to Acinetobacter calcoaceticus are present in bovine spongiform encephalopathy. Infect Immun 1999, 67:6591-6595.
6. Rozalski A., Sidorczyk Z., Kotelko K. Potential virulence factors of Proteus bacilli. Microbiol Mol Biol Rev 1997, 61:65-89.
7. Mishra M., Thakar Y.S., Pathak A.A. Haemagglutination, haemolysin production and serum resistance of Proteus and related species isolated from clinical sources. Indian J Med Microbiol 2001, 19:5-11.
8. Rocha S.P., Elias W.P., Cianciarullo A.M., Menezes M.A., Nara J.M., Piazza R.M., et al. Aggregative adherence of uropathogenic Proteus mirabilis to cultured epithelial cells. FEMS Immunol Med Microbiol 2007, 51:319-326.
9. Gutierrez-Ramos J.C., Bluethmann H. Molecular and mechanisms operating in septic shock: lessons from knockout mice. Immunol Today 1997, 18:329-334.
10. Sehic S., Li A.L., Ungar C.M. Blatteis, Complement reduction impairs the febrile response of guinea pigs to endotoxin. Am J Physiol 1998, 274:1594-1603.
11. Knirel Y.A., Kochetkov N.K. The structure of the lipopolysaccharides of Gram-negative bacteria. III. The structure of O-antigens. Biochemistry (Moscow) 1994, 59:1325.
12. Mielnik G., Gamian A., Doroszkiewicz W. Bactericidal activity of normal cord serum (NCS) against Gram-negative rods with sialic acid-containing lipopolysaccharides (LPS). FEMS Immunol Med Microbiol 2001, 31:169-173.
13. Vinogradov E.V., Radziejewska-Lebrecht J., Kaca W. The structure of the carbohydrate backbone of core-lipid A region of the lipopolysaccharide from Proteus mirabilis wild-type strain S1959 (serotype O3) and its Ra mutant R110/1959. Eur J Biochem 2000, 267:262-268.
14. Arabski M., Grabowski S., Konieczna I., Kaca W., Kondakova A.N., Perepelov A., et al. Serotyping of clinical isolates belonging to Proteus mirabilis serogroup O36 and structure elucidation of the O36-antigen polysaccharide. FEMS Immunol Med Microbiol 2008, 5:395-403.
15. Westphal O., Jann K., Himmelspach K. Chemistry and immunochemistry of bacterial lipopolysaccharides as cell wall antigens and endotoxins. Prog Allergy 1983, 33:9-39.
16. Kondakova A.N., Fudala R., Senchenkova S.N., Shashkov A.S., Knirel Y.A., Kaca W. Structural and serological studies of the O-antigen of Proteus mirabilis O-9. Carbohydr Res 2003, 338:1191-1196.
17. Galanos C., Luderitz O., Westphal O. A new method for the extraction of R-lipopolysaccharides. Eur J Biochem 1969, 9:245-249.
18. Arabski M., Wasik S., Dworecki K., Kaca W. Laser interferometric determination of ampicillin and colistin transfer through cellulose biomembrane in the presence of Proteus vulgaris O25 lipopolysaccharide. J Membr Sci 2007, 299:268-275.
19. Wasik S., Arabski M., Dworecki K., Slezak A., Kaca W. Influence of gravitational field on substance transport in gels. J Membr Sci 2010, 365:341-346.
20. Andersson J., Ekdahl K.N., Lambris J.D., Nilsson B. Binding of C3 fragments on top of adsorbed plasma proteins during complement activation on a model biomaterial surface. Biomaterial 2005, 26:1477-1485.
21. Schippers E.F., van't Veer C., van Voorden S., Martina C.A., le Cessie S., van Dissel J.T. TNF-alpha promoter, Nod2 and toll-like receptor-4 polymorphisms and the in vivo and ex vivo response to endotoxin. Cytokine 2004, 26:16-24.
22. Jaen O., Petit-Teixeira E., Kirsten H., Ahnert P., Semerano L., Pierlot C., et al. European Consortium on Rheumatoid Arthritis Families. No evidence of major effects in several Toll-like receptor gene polymorphisms in rheumatoid arthritis. Arthritis Res Ther 2009, 11:1-10.
23. Zheng B., Li Q., Wei C., Qin J., Shou T., Zhou R., et al. Lack of association of TLR4 gene Asp299Gly and Thr399Ile polymorphisms with rheumatoid arthritis in Chinese Han population of Yunnan Province. Rheumatol Int 2010, 30:1249-1252.
24. Sánchez E., Orozco G., López-Nevot M.A., Jiménez-Alonso J., Martín J. Polymorphisms of toll-like receptor 2 and 4 genes in rheumatoid arthritis and systemic lupus erythematosus. Tissue Antigens 2004, 63:54-57.
25. Swierzko A., Kirikae T., Kirikae F., Hirata M., Cedzynski M., Ziolkowski A., et al. Biological activities of lipopolysaccharides of Proteus spp. and their interactions with polymyxin B and an 18-kDa cationic antimicrobial protein (CAP18)-derived peptide. J Med Microbiol 2000, 49:127-138.
26. Simmons D.A.R. The structural basis of serological specificity in Shigella flexneri O-antigens. Biochem Soc Trans 1990, 18:1271-1272.
27. Kaca W., Arabski M., Fudała R., Holmström E., Sjöholm A., Weintraub A., et al. Human complement activation by smooth and rough Proteus mirabilis strains: the role of lipopolysaccharides and outer membrane proteins. Arch Immunol Ther Exp (Warsz) 2009, 57:383-391.
28. Futoma-Koloch B., Bugla-Ploskonska G., Doroszkiewicz W., Kaca W. Survival of Proteus mirabilis O3 (S1959), O9 and O18 strains in normal human serum (NHS) correlates with the diversity of their outer membrane proteins (OMPs). Pol J Microbiol 2006, 55:153-156.
29. Knirel Y.A., Perepelov A.V., Kondakova A.N., Senchenkova S.N., Sidorczyk Z., Rozalski A., et al. Structure and serology of O-antigens as the basis for classification of Proteus strains. Innate Immun 2011, 17:70-96.